Podcasts about blackrock neurotech

In this episode, Preston and Paolo discuss Tether's massive $13.7 billion profit, its growing strategic importance, and whether Wall Street banks will enter the stablecoin space. They also explore Tether's expansion into AI, real estate, and Brain-Computer Interfaces, alongside its big move to El Salvador. They also discuss what running Tether on Lightning means for payments and the future of tokenized assets in the UAE. IN THIS EPISODE YOU'LL LEARN: 00:00 - Intro 03:05 - How Tether achieved $13.7 billion in profits last year. 07:14 - Why Wall Street banks might try to compete in the stablecoin space. 13:11 - The impact of running Tether on the Lightning Network via TAP. 20:07 - Challenges and opportunities in Lightning Network routing. 22:04 - The future of tokenized equity in the UAE and global accessibility. 30:18 - Tether's massive move to El Salvador and its 70-story building project. 33:32 - How Tether is expanding into AI with DeepSeek and open-source solutions. 35:11 - The role of Reelly Tech in real estate transactions. 41:25 - Why Tether invested $200M in Blackrock Neurotech and its AI SDK strategy. 47:15 - How all these moves fit into Tether's long-term vision. Disclaimer: Slight discrepancies in the timestamps may occur due to podcast platform differences. BOOKS AND RESOURCES Article on How Tether Achieved $13.7 Billion in Profits Last Year. Article on Tether on the Lightning Network.  Article on Tether's move to El Salvador.  Paolo's X Account. Check out all the books mentioned and discussed in our podcast episodes here. Enjoy ad-free episodes when you subscribe to our Premium Feed. NEW TO THE SHOW? Join the exclusive TIP Mastermind Community to engage in meaningful stock investing discussions with Stig, Clay, Kyle, and the other community members. Follow our official social media accounts: X (Twitter) | LinkedIn | | Instagram | Facebook | TikTok. Check out our Bitcoin Fundamentals Starter Packs. Browse through all our episodes (complete with transcripts) here. Try our tool for picking stock winners and managing our portfolios: TIP Finance Tool. Enjoy exclusive perks from our favorite Apps and Services. Get smarter about valuing businesses in just a few minutes each week through our newsletter, The Intrinsic Value Newsletter. Learn how to better start, manage, and grow your business with the best business podcasts. SPONSORS Support our free podcast by supporting our sponsors: Hardblock SimpleMining Unchained Netsuite Found Fintool The Bitcoin Way Shopify Vanta Onramp TurboTax PrizePicks Fundrise Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://theinvestorspodcastnetwork.supportingcast.fm

Are you ready to boost your career in a unique way? Today's epsode is designed for anyone curious about starting a podcast—whether you want to explore it as a passion project, enhance your career, or dive into science communication. Welcome to a milestone moment – the 100th episode of Neurocareers: Doing the Impossible! For this special occasion, Milena Korostenskaja, host of Neurocareers, is stepping into the hot seat! Instead of hosting, Dr. K will be interviewed by one of her incredible former guests, Dr. Courtnie Paschall.         Joining the discussion pane are powerful podcasting experts: Stephen Hou, an amazing co-host of the Neurratives podcast; Harrison Canning, known as The BCI Guy and an inspiring science communicator; and Mike McClellan, a brilliant editor who brings the magic to Neurocareers behind the scenes. Together, they'll explore how to launch your own podcast and discuss how podcasting can elevate your career in science and tech, helping you build valuable networks, showcase your expertise, and make a real impact. As a special treat, you'll also hear us answering live questions from our audience! So, if you're thinking about starting a podcast or looking to take your show to the next level, join the panelists for practical tips, fresh ideas, and unique insights you won't find anywhere else (not even on ChatGPT!). Here's to the next step in your career – let's dive in! About the Podcast Panel: Courtnie Paschall, PhD A researcher and entrepreneur in neurotechnology and a former guest on Neurocareers: Doing the Impossible! takes the mic to interview podcast host Milena Korostenskaja and amazing podcasters in the neurotech field, Stephen Hou, Harrison Canning, and Mike McClellan, for the special 100th episode. Stephen Hou  Is an engineer at BlackRock Neurotech and co-host of Neurratives: A Podcast about Neuroscience in Fiction alongside Nick Halper. The show humorously explores neuroscience themes in popular media, with topics ranging from brain-computer interfaces in musicals to neuroethics in sci-fi films like JUNG_E. Harrison Canning  Is the creator of The BCI Guys, the host of the Brain Stream Podcast, a Neurotech Innovation Strategist at Blackrock Neurotech, and a Master's student at Harvard Medical School. Harrison focuses on neuroscience communication and was previously featured on Milena's Neurocareers podcast in an episode about his career in Science Communication.  Mike McClellan Is an aerospace engineer by day and podcast editor by passion. He is an extremely multi-talented guy – with degrees in physics, mechanical engineering, music composition, and music theory. He will offer insights into the technical side of podcast production. Milena Korostenskaja, PhD (Dr. K), is a scientist specializing in neuroimaging, brain-computer interfaces, and neurostimulation. She currently works as a BCI and Neurostimulation Scientist at g.tec medical engineering and offers career coaching through The Institute of Neuroapproaches. Dr. K also hosts the podcast “Neurocareers: Doing the Impossible!” About the Podcast: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for people in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities job applicants face in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume, and cover letter development Neurotech / neuroscience job interview preparation and practice Networking strategies to connect with professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Andy Jassy freut sich über die Reduzierung von 50 Entwicklertagen auf wenige Stunden bei der Upgradezeit für Java-Anwendungen. Warum glaubt Klarna noch weiter sehr viele Leute entlassen zu können? Cerebras Systems hat einen neuen KI-Inferenz-Dienst gestartet, der laut dem Unternehmen 20-mal schneller als vergleichbare cloud-basierte Dienste mit Nvidias leistungsstärksten GPUs ist und deutlich niedrigere Kosten pro Token bietet. Tether, das Unternehmen hinter der gleichnamigen Kryptowährung, investiert angeblich laut WSJ mit Hilfe von Christian Angermayer in scheinbar unverwandte Unternehmen wie Northern Data und BlackRock Neurotech. Werbung: Melde dich jetzt an zum Webinar von LIQID: „Warum Profis auf Venture Capital setzen“ am 7. September um 11 Uhr. Philipp Glöckler und Philipp Klöckner sprechen heute über: (00:00:00) Intro (00:09:30) Klarna (00:22:00) Nvidia Friede Freude AI Kuchen (00:35:00) AI Einsatzgebiet Andrew Jessy Amazon Q (00:40:10) Tether (00:44:30) Uber FSD (00:45:20) Yelp (00:47:00) Reddit (00:55:35) Crowdstrike (01:00:45) Salesforce (01:04:00) Birkenstock Shownotes: Klarna: Handelszeitung, Tech.eu, Pips LinkedIn OpenAI Funding: WSJ Cerebras: X, Siliconangel Angermayer Tether: WSJ Uber FSD: Reuters Yelp: The Information

No signs of Bitcoin miner capitulation despite plummeting revenueTether Invests $200 Million in Blackrock Neurotech, Launches Evo DivisionPretty ordinary stuff Traders seem unfazed by Bitcoin correction

Host Jennifer Sanasie breaks down the latest news in the crypto industry from the letters of support for CZ to Tether's investment in a brain-computer interface company.To get the show every day, follow the podcast here."CoinDesk Daily" host Jennifer Sanasie breaks down the biggest headlines impacting the crypto industry today, as a Washington court received 161 letters of support for Binance co-founder Changpeng “CZ” Zhao. Plus, crypto markets are in the red amid renewed fears of U.S. stagflation and Tether invested $200 million to acquire a majority stake in brain-computer interface company Blackrock Neurotech.-Consensus is where experts convene to talk about the ideas shaping our digital future. Join developers, investors, founders, brands, policymakers and more in Austin, Texas from May 29-31. The tenth annual Consensus is curated by CoinDesk to feature the industry's most sought-after speakers, unparalleled networking opportunities and unforgettable experiences. Register now at consensus.coindesk.com.-This episode was hosted by Jennifer Sanasie. “First Mover” is produced by Jennifer Sanasie and Melissa Montañez and edited by Victor Chen.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 92 discusses Converting Visitors to Customers with David Gaz.Based out of Los Angeles, CA, David Gaz is the Founder/CEO for The Bureau of Small Projects.  A company that leverages their expertise and relationships to help small businesses who are making a difference converting visitors into customers.Some of The Smartest People in The World Work with The Bureau of Small Projects.  Literally rocket scientists and brain surgeons:  Bill Nye - The Science Guy, Stanford University, Blackrock Neurotech, the country Switzerland, AmyriAD who is bringing a revolutionary Alzheimer's treatment to market, and many, many more. The Bureau of Small Projects leverages their branding, web development, and marketing experience with Fortune 500 companies and major Brands using all the “trade secrets” that they have developed over the years to help SMALL businesses, startups, and nonprofits make a BIG impact. David recently directed the critically acclaimed documentary, Kindness Is Contagious.  A film all about being nice and the benefits of being nice, narrated by Catherine Ryan Hyde, bestselling author of the book and movie, Pay It Forward. He has received numerous awards in advertising, photography, film, and has over 20 years of experience with major brands such as Levi's, Sony, IBM, Kellogg's, Disney, as well as world class museums and cultural centers. He writes about branding for Forbes, Newsweek, and Fast Company.  His work has been featured in Communication Arts (Including Cover), Fast Company, Graphis, The Huffington Post, The San Francisco Examiner Sunday Magazine, The Chicago Tribune Sunday Magazine, NOTCOT, and numerous blogs. David has spoken at events all across the country. The Business of Business, topics are divided into 4 Categories: Management, Operations, Sales, and Financial. Target Audience is Business Owners, C-Level Executives, Management, and anyone considering starting a business. Support the showHelping You Run a Successful Profitable Business !For Business Consulting or to be a Podcast Guest - Contact me at: www.bcforg.comLinkedIn: https://www.linkedin.com/in/brian-fisher-72174413/

KSQD 2-07-2024: The epidemic of PTSD in the military results in using psychedelics for treatment; An examination of Neuralink and Blackrock Neurotech brain-computer research progress; The off-label use of Mupirocin for Lichen Sclerosus of the vulva; Training an AI to learn language like a human child ;Post-death human composting is approved in California; Sexually transmitted infections are increasing in the elderly; RvT4 molecule to reduce inflammation in rheumatoid arthritis and reduce plaque in atherosclerosis

En un post en X, Elon Musk dijo que su compañía Neuralink implantó con éxito uno de sus chips cerebrales inalámbricos en un humano. La empresa busca conectar cerebros biológicos a computadoras para ayudar a confrontar afecciones neurológicas complejas. Cabe destacar que este es el primer implante hecho por Neuralink, pero no el primer implante hecho en humanos. Blackrock Neurotech hizo el primer implante en 2004, Synchron hizo la primera interfaz entre cerebro y computadora para tuitear en una cuenta en 2021, la escuela suiza EPF hizo un implante que ayudó a un paralítico a caminar gracias a la conexión entre su cerebro y su cuerpo, Precision Neuroscience desarrolló un proceso más simple llamado “microhendidura craneal” para implantes que son más delgados que un cabello e hizo su primer estudio clínico el año pasado.Para esta y más noticias, escucha el podcast de Noticias de Tecnología ExpressDisponible en Spotify y en Apple PodcastsPuedes apoyar la realización de este programa con una suscripción. Más información por acá

Today's episode is a roundup of some of the most impactful medtech headlines of 2023. We had a handful of news stories this year that caught our attention. Join Fast Five hosts Sean Whooley and Danielle Kirsh as they discuss the following: Layoffs – Medtech has shown some resilience in the present economic environment. Some major medical device companies released positive earnings this year. However, others announced headcount reductions, citing macroeconomic headwinds. Hear which companies reduced their workforce the most in 2023 and some of the reasons they listed for the reduction. Personnel moves – Contrary to layoffs, some big names in medtech executive leadership also left their posts for new jobs in 2023. Some of our top stories were about CEOs leaving for a new company, retiring or another reason. Whooley and Kirsh discuss some of the largest personnel moves that shook the industry this year, including J&J MedTech's leadership change. Silicon Valley Bank closure – Silicon Valley Bank's closure in March affected several medtech companies. SVB has been a huge name in the tech and startup world since its founding in the 1990s. The Fast Five hosts talk about the companies that were backed by SVB and the surprising story of a medtech company that benefitted from the closure. Mergers & acquisitions – Medtech had some pricey acquisitions in 2023. Despite some macroeconomic challenges, M&A activity was seemingly up for the year. Hear about one of the largest deals of the year and some of the other deals in medtech in 2023. Brain-computer interfaces – Many companies joined the playing field for that technology or had breakthroughs in 2023. Blackrock Neurotech, BrainGate, ClearPoint Neuro, Neuralink, Synchron and more race to bring brain-computer interface (BCI) tech to market. Learn about the top companies in the BCI space and what their technology does.

Welcome back to the mind-blowing extravaganza that is Neurocareers: Doing the Impossible! Podcast! Get ready to buckle up and dive headfirst into the captivating world of brain-computer interfaces (BCIs) with none other than the incredibly witty and brainy Harrison Canning, a.k.a. The BCI Guy! Picture this: Harrison, the Neuroscience Communications Coordinator at Blackrock Neurotech, is your go-to guru when it comes to making brain-computer interfaces a piece of cake for everyone. With his media company, The BCI Guys, he whips up educational, entertaining, and easy-to-understand videos that break down complex concepts like a boss! But hold on tight, because we're not just scratching the surface here. Harrison's journey into the neurotech industry is a wild ride! Armed with a multidisciplinary background in neuroscience, design, ethics, and communications, he's on a mission to revolutionize the field and advocate for the ethical development of mind-boggling neurotechnologies that enhance lives and push human potential to unimaginable heights! In this electrifying episode, we'll uncover the secrets behind brain-computer interfaces and their jaw-dropping potential to transform our lives. Harrison spills the beans on the importance of science communication in the wacky world of neuroscience and even shares some insider tips on how YOU can get in on the action! Prepare to have your mind blown and your funny bone tickled! So, whether you're a neuroscience nerd, a curious cat, or simply someone who loves to laugh and learn, this episode is an absolute must-listen! Join us as we embark on an adventure of epic proportions with The BCI Guy himself, Harrison Canning. Get ready to unleash your inner neurogeek and discover the mind-bending possibilities that await us in the realm of brain-computer interface communication! Plug in your headphones, fire up the podcast, and prepare to have your brain twisted into knots of awe and amusement! Neurocareers: Doing the Impossible! The podcast with Harrison Canning is about to rock your world! About the Podcast Guest: Harrison Canning works as the Neuroscience Communications Coordinator at Blackrock Neurotech and, through his media company, The BCI Guys, creates educational, entertaining, and easy-to-understand videos about brain-computer interfaces. He applies his multidisciplinary background in neuroscience, design, ethics, and communications to advocate for the ethical development of neurotechnologies that will improve patients' lives and expand human potential. Check out the information about Harrison by following these links: - Harrison's Website: https://harrisoncanning.com/  - Harrison's LinkedIn: https://www.linkedin.com/in/harrison-canning-%F0%9F%A7%A0-440bb815a/ - BCI Guys YouTube: https://www.youtube.com/@BCIGuys/featured  About the Podcast Host: The Neurocareers podcast is brought to you by The Institute of Neuroapproaches (https://www.neuroapproaches.org/) and its founder, Milena Korostenskaja, Ph.D. (Dr. K), a neuroscience educator, research consultant, and career coach for students and recent graduates in neuroscience and neurotechnologies. As a professional coach with a background in the field, Dr. K understands the unique challenges and opportunities facing students in this field and can provide personalized coaching and support to help you succeed. Here's what you'll get with one-on-one coaching sessions from Dr. K: Identification and pursuit of career goals Guidance on job search strategies, resume and cover letter development, and interview preparation Access to a network of professionals in the field of neuroscience and neurotechnologies Ongoing support and guidance to help you stay on track and achieve your goals You can always schedule a free neurocareer consultation/coaching session with Dr. K at https://neuroapproaches.as.me/free-neurocareer-consultation Subscribe to our Nerocareers Newsletter to stay on top of all our cool neurocareers news at updates https://www.neuroapproaches.org/neurocareers-news

Today on the show, Steven and Shaun review the week here at Double Tap. AMI's Grace Scoffield joins the team to bring us the news, featuring some serious news from Amazon's Ring, which has just settled with the U.S. Federal Trade Commission for a whopping $5.8 million over privacy violations. We're also saying goodbye to celebrity voices on Amazon's Alexa-enabled devices, and the BrailleWear glove developed by ORama AI is set to revolutionize the way people read Braille. Also, BlackRock Neurotech is making strides with their brain implant technology, and we discuss the future of the Microsoft Soundscape app, which is going open-source in June. And we get into the nitty-gritty of some cool tech updates. If you've got the Hable One Braille input keyboard, you'll want to tune in for Shaun Preece's tips on updating your device. We're also reviewing the official ChatGPT app from Open AI, which just launched in 40 new countries, courtesy of Thomas Domville, also known as Anonymous. We also bring up our earlier discussion this week on the quality of audio description with blind journalist and advocate Robert Kingett. He's been working with Netflix to ensure their original content is audio described, and he's got some fascinating insights to share. And of course, we're getting hyped for Apple's Worldwide Developer Conference and the much anticipated Apple headset wearable device. Useful links from this episode: Petition to request Microsoft doesn't end support for SoundScape: https://chng.it/yz7H8vDdTB Thomas Domville from AppleVis talking about the official Chat GPT app for iOS: https://www.applevis.com/podcasts/introduction-official-chatgpt-ios-app Get in touch with the Double Tappers and join the conversation: Email: feedback@doubletaponair.com Call: 1-877-803-4567 (Canada and USA) / 0204 571 3354 (UK) Twitter: @BlindGuyTech / @ShaunShed / @DoubleTapOnAir Mastodon: @DoubleTap YouTube: DoubleTapOnAir

Joe Allen has become a mainstay on our War Room screens over the last few years, his understanding of how technology is negatively affecting our lives and his analysis of how we push back is second to none. The rise of AI, nano technology, genetic experimentation, biometric payment systems, digital ID and digital currencies are all new technologies that are creeping into our everyday lives. Who controls them? What is their purpose? Do we have a choice to opt out? How are governments planning on using these to control their citizens? Joe answers all of these questions as he takes us into a new reality that is marching towards artificial general intelligence. Joe Allen is the is Transhumanism editor at War Room: Pandemic. He is a fellow primate who wonders why we ever came down from the trees! Joe studied religion and science at the University of Tennessee and Boston University and writes about ethnic identity, transhuman hubris, and the eternal spiritual quest. His work has appeared in The Federalist, ColdType, The American Thinker, The National Pulse, This View of Life, The American Spectator, IBCSR: Science on Religion, Disinformation, and elsewhere. Follow Joe at.... Substack: https://joebot.substack.com/ GETTR: https://gettr.com/user/JOEBOTxyz Twitter: https://twitter.com/JOEBOTxyz?s=20 War Room: http://warroom.org/ Interview recorded 12.4.23 *Special thanks to Bosch Fawstin for recording our intro/outro on this podcast. Check out his art https://theboschfawstinstore.blogspot.com/ and follow him on GETTR https://gettr.com/user/BoschFawstin and Twitter https://twitter.com/TheBoschFawstin?s=20  To sign up for our weekly email, find our social media, podcasts, video, livestreaming platforms and more... https://heartsofoak.org/connect/ Please subscribe, like and share! Transcript [0:22] Joe Allen, thank you so much for joining us on Hearts of Oak today. Peter, very glad to be here. Thank you very much. Not all. I know many of our viewers will have seen you regularly on War Room as a transhuman editor. What does it take to be a transhuman editor? How did that end up? You've being in the War Room. Tell us about that. You know, well, transhumanist or transhuman, although I would say this, Peter, that I think transhuman editor might be most accurate now. Part of the gig obviously is a 24-7 screen time. So I think that my cyborg status is pretty much solidified at this point. You know, Steve reached out to me just a little over a year ago, just like two years ago, And I'd written an article about the transhumanist quest, to upload for the Federalist. And I'd been writing a series of articles about technology that dipped into transhumanism quite a bit. He got a hold of that article about transhumanists and their desire to upload their souls and liked it. And it was quite odd. I don't wanna get too long into the story, but a friend of mine who had tipped me off to the War Room some year or so prior to that. [1:49] He had tipped me off to the War Room. I watched it. I watched an interview with Steve on PBS. It was this long, uncut interview with Lester Holt. And I was like, man, I've got to get a hold of this guy, Steve Bannon. And, but the way it works, you don't just call up Steve Bannon. And no one I knew had his contact. So I just put it out of my mind. I roamed across the country during the pandemic, ended up in Montana. And that same friend about a year later tells me that Steve gave me a shout out on the war room. And I thought, what? And it wasn't two weeks or three weeks after that that I checked my Twitter DMs, which I never ever did at the time. It was a different handle. [2:34] And there was Cameron, the producer, asking if I would come on the show. And so, but it was already too late. Got back to him, went on the show. Steve asked me if I'd like to join the war room that day. And here I am. It's always interesting who connects you, to me. It was just Miller giving credit to who connected me with Steve. What Steve does with the War Room is phenomenal and he is a machine in terms of production, in terms of knowledge, in terms of what he pushes out. Yeah, love watching you on that. I think you're on Charlie Kirk recently as well, a few days ago. I mean, yeah, that's right.   Absolutely brilliant. But if we, you can, for the viewers, you can obviously find you at JoeBotXYZ on the GETTR and on Twitter. Obviously, he has his Substack account. All the links are in the description. And that's just JoeBot.Substack.com you can find there and sign up to his regular wisdom. But I probably, Joe, when I think of transhumanism. I think the most powerful men in the world, Sleepy Joe, Supreme Court judges, don't know who women are, Elon Musk. And I'm thinking maybe transhumanism would be an improvement. [3:57] You know, I wouldn't deny that. In many ways, I think that if the world was run by a Satanist cabal, at least they would have a plan. So yeah, it's interesting. Probably the most famous proponent of transhumanism, at least in elite circles, is Klaus Schwab. And I think people just, they really dismiss Schwab oftentimes because he tends to speak, and he and his co-author write in vacant corporate platitudes for the most part. But I do think that he's smart enough to know which way the wind's blowing. And the wind is definitely blowing in the direction of holding up technology as the highest power. And so really, I think his fourth industrial revolution in 2016 was in many ways a kind, of clarion call to the world that this is the way we are going. And some of it is him looking around the scene and evaluating it. Some of it is his own enthusiasm. He has this really strange, naïve enthusiasm for transhumanist technologies. [5:16] That represents a really, really important moment in Western history and perhaps world history because of the open declaration that technology will be the way forward, not political ideology, and in their view, certainly not religious ideology, but technology. [5:38] Well, let's maybe delve into the most relevant transhumanist technologies. You've got a number of things will be on people's radar, nanotechnology, you look at mRNA and that ability, your digital ID, I guess, world governments, institutions tracking us, monitoring us, you could chat, GBT has a lot of headlines recently. And when people talk about kind of most relevant transhumanist technology, how do you kind of start unpacking that? [6:12] It can get complicated, but to break it down as simply as possible, two categories have to be distinguished there, one being technocracy, ruled by expert, and in its more modern form, ruled by expert through science and technology. And then on the other end you have transhumanism itself, which is in some ways separate from that. They overlap a great deal, but it is ultimately two separate, these are two separate movements. That Patrick Wood put it best, I'll paraphrase him, as technocracy is to a society, transhumanism is to the individuals within that society. I think that really does encapsulate the overlap quite a bit. [7:05] So when you talk about something like digital identification or digital currencies, central bank digital currencies, these I would say fall more under the category of technocracy. It's more of a way of organizing a society. It's a social structure based on technological systems of control. And on the other side, you've got transhumanism. And this is much more of, I would say, a kind of spiritual quest on the part of the people who are involved. You could say that it is many decades old. You know, the term transhumanist coined by Julian Huxley, 1956, I've got an essay collection, New Bottles for New Wine, and the opening essay was a lecture in 1956 entitled Transhumanism. He isn't really talking about technology so much in this though. He's more talking about how science will transform human beings. [8:03] He's hinting at technology, but for the most part, he grounds it in science. And of course, technology by and large emerges from the scientific method and mathematical deduction. So it fits, but it really wasn't until the 80s or so that you started seeing a lot of people take on this term transhumanism as a description of using technology to transform the human being. FM 2030 I think was probably the first major figure, but then Max Moore, a philosopher, was probably the one who put the stamp on the term transhumanism in this realm. So relevant technologies. I think the most relevant, especially now, artificial intelligence, creating a digital brain. The belief being that artificial intelligence will have limitless memory. Artificial intelligence will be able to scrape over basically unlimited data, as much data as you can feed into it. [9:08] And of course, it's going to have better pattern recognition than human beings. It's going to be able to pick out patterns in that vast amount of data in a way that no human being would be able to. It's gonna be able to do it at really, really fast speeds, right? So human brain operates on neurochemical processes, artificial intelligence computers in general, that processing moves at the speed of light. So there's a religious idea behind it that artificial intelligence is becoming and will become a sort of God to human beings. How do you merge yourself with that God? How do you reap the benefits and blessings of that God? Descending from there, you've got robotics. Which requires artificial intelligence for sophisticated systems of control. [9:58] You also have brain-computer interfaces, so that could be anything from these screens that we're speaking through, and I think that is a valid interpretation, hence my transhuman editor label. And then you've got the non-invasive brain-computer interfaces, It's kind of skull caps that read the brain in increasingly great detail. They don't require implants. Some of them, they're planning to roll out, different corporations are planning to roll out sort of AirPod-like brain computer interfaces or small bands that fit on the back of your head used for anything from monitoring employees' mental states to controlling actual computer systems. Nita Farahany is probably the leading expert on the non-invasive brain computer interface, if your listeners would like to look into it. But then of course you have the implanted brain computer interface. You got three major corporations working on that. [11:01] Neuralink, which has yet to get FDA approval. You've got a hole cut out of your skull, chip put in, about 1,024 wires or more if they can get them into the brain, those read the brain, and then allow the human being to project thoughts into a computer system. At the moment, there's not really any input. They've been able to do muscular movements and other things, but for the most part right now, the technology is only output. And so any input would have to come in through the traditional method, visual audio. And then two other corporations though, that are right now implanting their brain computer interfaces in human brains. You've got Synchron out of Brooklyn. [11:49] And Synchron is instead of drilling a hole, you send a kind of stent, an electronic stent up the vein into the brain at the jugular. And it sits within the vein and is able to read the neurons around it. I don't know what their count is, probably something like six, seven, eight, less than 10 if I'm not mistaken. But they have implanted them and people who are locked in, who've had strokes, things like that, are basically being experimented on with the intention of Tom Oxley, their CEO, hopes that eventually that technology will be able to be used to throw your emotions to other people. Kind of hive mind-ish idea. And then you've got BlackRock Neurotech invested in by Peter Thiel, and they're based out of Utah. And again, a different sort of technology, the way it works, you get it under the skull on top of the brain. It's a micro electrode array patch that sits on top of the brain. [12:58] I think that they have around 36 patients that are currently implanted with that technology. And again, it allows them to operate robotic arms. It allows them to translate their thoughts into text on screen, things like that. Moving down from there you have the sort of biological, Neurological and biological [13:22] technologies so the the neurological technologies this kind of feeds into the brain-computer interface is just [13:30] transcranial stimulation whether it's magnetic or whether it's kind of a a sonogram of, sorry, What's the word I'm looking for? Using sound waves anyway, sorry, I blanked on the very common term. But you use the stimulation to do various things, change mood, change the ability to concentrate, those sorts of things. And then, of course, you have the implanted version of them. There's like 160,000 of those, and those range from everything from eliminating Parkinson's tremors to eliminating depression, oddly enough. [14:10] And then I think the most famous and the thing that really captures people's imagination, genetic engineering. Genetic engineering has been a thing for quite some time. The first real genetic engineering projects come out of Stanford in the 70s. But with the advent of CRISPR, basically a molecular complex found in E. coli, CRISPR-Cas9, that was really discovered, I would say, 2011. It was kind of a piecemeal discovery process. [14:42] But now CRISPR is used for all sorts of things. And the advantage of CRISPR is that it allows the geneticist to go in and spot edit the genome. So initially it was to cut out nucleotides in a faulty gene to shut the gene down. But now they're able to actually cut out and insert corrective nucleotides to change the gene, to correct the gene, to heal disease. And the goal going forward for a lot of people, not everyone by any means, but for a lot of people, the goal going forward is to use that to enhance human beings, to give us greater intelligence, to give us greater strength, and you know, whatever else may be desired. Beauty. Mood, temperament, all those sorts of things. So that hopefully gives your listeners a roadmap, artificial intelligence, robotics. [15:41] Brain-computer interfacing, neuro-enhancement, and genetic engineering. Two questions. One, obviously, one argument on this is this is just technological advancement. This is just humans bettering themselves. But then another part of that, when you mentioned some of those things, you realize that it is, much of it is very much about the person. It's not technology at arm's length, but actually people may not have control or the ability to decide yes or no that it will happen because it's on the person as opposed to a phone that you can pick up and set down if you can't actually pick it up and set down because it's part of you. But what are your, one, that this is just technological advancement, but then the flip other side that maybe humans will not be able to decide whether or not they're part of this. It's a thorny topic for a lot of reasons. One, a lot of transhumanists argue for a morphological freedom, right? So guys like Max Moore, guys like Zoltan Istvan, they talk about it in terms of freedom. It's the freedom to be able to alter one's body or use technologies in any way they see fit, even if it puts off the rest of us in normal human society. [17:03] Then you have the more kind of implicit totalitarianism that you see in the singularity prophecies, right? So Ray Kurzweil being the most famous, it's just the idea that these technologies have always increased in complexity and effectiveness at an exponential rate. Then that exponential curve will continue until it reaches basically vertical, basically infinite advancement. He calls this a singularity at which technology is completely out of human control and the technology is making all the decisions. And he predicts 2045 is the date we'll hit the singularity. [17:43] And so the implicit totalitarianism there is that not that these guys are creating technologies to control everyone, the idea there, and they never own up to it, but this is definitely there. The idea is that you're creating a technological system that is inescapable and a technological system that has ultimately the final say in whatever sort of state that human psychology or human society is in. And so, even if you don't believe in something like that, even if you don't believe something like that's possible, to the extent that ideology is driving the people making the technologies and is also kind of hypnotizing the public with this technophilia, you end up in a situation where whether the singularity comes or not, whether anything like that happens or not, you have a kind of techno-religion that sees, really the rise of artificial intelligence, nano robotics and genetic engineering as this sort of second coming or the realization of God. And I really do fear, Peter, that a lot of people are so enamoured by it that the effectiveness of the technology won't be as important as the social and psychological effects. Now moving over into the more totalitarian, like openly totalitarian end of it. [19:10] In the West, people really don't talk like that. Even Klaus Schwab, if you read his writing or really listen to what he's saying outside of the small snippets, and certainly if you listen to Yuval Noah Harari to any length, neither of them are talking about creating a digital dictatorship. Schwab sounds more like it than Harari. Harari, if you read Harari carefully or even just read him at all, or listen to him carefully or just listen to him at all. You hear him over and over again, warning that these technologies are a recipe for digital dictatorship, right? So this idea of hackable humans, yeah, he's very unsentimental and he's very hostile to religion. He mocks religion a lot, so it's very off-putting. But what he's talking about is the rise of the scientific paradigm in which human beings, don't have free will. It's a scientific paradigm that holds that our decision-making process is nothing more than the bubbling up of neurochemical processes, and that with sufficient surveillance technology, your phone being a big one. [20:19] Sufficient surveillance technology allows governments and corporations to monitor your behaviours and as he would put it, to know you better than you know yourself. Then they're able to manipulate the population en masse, and they're able to target individuals for direct psychological manipulation. And because of this belief that free will is an illusion, people won't even realize that they're being manipulated. They will think they're making their own decisions. Now where you do see a sort of overt application of this, you see it in China. China has you know, they're they're really it's unclear how advanced their artificial intelligence is, it's unclear how advanced their genetic engineering projects are but they have far fewer ethical constraints on, genetic engineering and they have, [21:15] basically, no real ethical constraints that I'm aware of on the development of artificial intelligence up to artificial general intelligence now, Really is officially speaking neither do we in the West? But for China, the real advance they have made in artificial intelligence is in surveillance technology. And so of course in any major city in China, you've got wall to wall surveillance sensors. And those are more and more starting to incorporate biometric sensors, biometric analysis of video footage or other biometric data, including genetic data. And so China, I think, represents kind of an overt expression of what we're talking about when transhumanism meets totalitarianism. And it's very chilling because more and more people at the World Economic Forum, including Klaus Schwab, seem very amenable to the Chinese model. And more and more, I think, people in America implicitly are embracing something like the the Chinese model. [22:21] Obviously one of the, just before we want to move on some of the individuals involved, but one of the headlines I think which you reposted was a zero hedge headline, 1st of April. The headline was unprecedented Chinese genetic experiment may lead to an army of radiation resistant super soldiers. They talk about Frankenstein like experiments with manipulation of human DNA. I guess the danger is that somewhere like China, you say it doesn't have restrictions, but also it doesn't have a sense of the individual, where in the West, the individual makes their choices and they can choose yes or no, where in China you don't have that ability. When you have stories like that out of China, it makes you wonder what else is happening, but in a country that doesn't have those controls and doesn't have those personal individualistic controls, then it's frightening where that can go, I guess. Yeah, I think that is a great example of two things. One, the sort of distracting over sensationalization of what's going on. It was an experiment. [23:31] It was an experiment on human embryos. Basically, they're fusing, they're injecting or stitching water bear genes into human genes, right? Of water bears and those tiny little microscopic creatures that I guess look like bears. They look more like some kind of monstrous doodle bug to me. But the idea then being that because water bears are resistant to radiation, these resulting humans would also be resistant to radiation. One of the things that I covered and looked into quite a bit was the creation of human monkey chimeras in China. [24:09] This was done in partnership with the Salk Institute in California, but the human monkey chimeras, basically a chimera is taking two different types of stem cells, right, two different species or multiple species stem cells and fusing them together to create a sort of hybrid creature. This has been done a lot in mice, but this was, these were human stem cells blended with, I believe it was macaque monkey stem cells and we're chimpanzee, whatever. And they let them grow until like 30 days, then offed them, right? Mass abortion basically. [24:51] And another great example, Ha-Xiang Hui, the Chinese geneticist, in I believe it was 2018 announced that he had created the world's first, at least known, CRISPR babies, a pair of twins whose father was HIV positive. So he went in and used CRISPR to alter their, it's a gene that is responsible for the enzymes on cellular membranes, a defensive enzyme that would give them immunity or at least resistance to HIV. He was of course imprisoned by the Chinese Communist Party after all of the global ethical outrage. Many would say and I think it's probably correct that the reason they imprisoned him is mainly because he bragged about it not because he did it. But, anyway, I think that in many ways the, in the same way that killer artificial intelligence is a is a diversion from the real dangers of just minimally powerful artificial intelligence or social control or surveillance. And in the same way that an implanted brain-computer interface kind of distracts attention away from the real human-machine symbiosis that occurs through our relationship with smartphones and other digital devices. In that same way, the focus on this idea of horrific mutants, [26:16] such as a human monkey chimera, or a part human, part water bear nuclear war super soldier, A, it's very unclear whether any of those creatures would ever develop into anything anyway, right? More than likely, they would just die as the genetic monsters that they are. But even if that was done, you're talking about a tiny minority of people We'll take another 10 to 20 years to really see what the realization of that means, What's more important? I think is something like the vast experiments done on the human population with mRNA injections, That alone is enough to give us pause. You know, it is terrified about half of us and [27:02] for very very good reason it has completely hypnotized seemingly the other half of us, which is also extremely alarming. But I really think that it's the extreme ends of these technologies It's very important to look at them because that tells you where they want it to go, but for the immediate, for right now for the present time. I think that the most important thing to look at is these these more mundane experiments being done on the whole on whole populations such as the mRNA injections such as as human smartphone symbiosis, and such as AIs like the chatbots, the chat GPT. Well, let's get into it. I want to talk about some of the individuals. I was saying actually what are the vision guiding these technologies, but the vision comes with the individuals. And of course, you've got Bezos with Amazon One, Sam Altman, who I actually hadn't come across until you put out the article about the biometric world ID. Someone like Jeff Bezos, us on the right on the conservative side, or we don't like. But then you've got Peter Thiel, you've got Elon Musk, and then there's confusion because they're pushed towards some of these technologies. So, I mean, give us a, you've touched on some of the figures, but maybe touch on some of those who are some of the key individuals pushing some of these technologies? [28:30] You know, since you mentioned them and none of them, none of the ones you've mentioned other than Peter Thiel are open transhumanist and even Peter Thiel now basically says transhumanism is a kind of a past, it's a fad that has passed. And in some sense he's correct because transhumanism was a very localized school of thought that whose ideas influenced a lot of people. And now you wouldn't call it transhumanism. You would call it the fourth industrial revolution, or you would call it the internet or you would call it bio-digital convergence, something like that. So just going across that spectrum and I'll just go from left to right. You would say, and I don't think that left and right really don't apply here because what you're talking about is an orientation towards a higher power technology and it really does cross the political spectrum. There's every reason for people on the right to want to use these technologies as there is for people on the left. So. Bill Gates, though, I think is at least most associated with kind of left-wing thinking, even if he's not really a leftist in any meaningful way. [29:36] He is probably, he's been the most resistant to publicly espousing transhumanist goals, right? He's more and more moving in that direction, especially with the release of the GPT technology. But, you know, for him, it's always this sort of latent thing. He's much more focused on the immediate so far as I can tell and he's also to me the most condemnable of all those individuals because of all the influence that he's wielded to [30:05] force these technologies on people in a technocratic fashion moving over to Jeff Bezos, you know, There are a lot of reasons that Jeff Bezos has gone under the radar because he is, He like gates. He's not been all that outspoken but just look at three different aspects of his career, four different aspects, sorry, four. Number one, the entire Amazon structure is technocracy personified, right? So a fulfillment center is a top-down control structure built off of algorithms and some advanced artificial intelligence that either employs robotics to do the work or it turns humans into kind of human algorithm symbiotes. So people literally sit around all day on their phones taking direction and they're monitored and artificial intelligence scrapes up that data to figure out how to make the system more efficient. It is without a doubt, the most effective digital super organism that exists on the planet, or at least among the maybe military grade super organisms are more powerful. Second, his entire infatuation with going out into outer space and... [31:22] At one point he was speaking at the National Cathedral. He talked about how maybe in one vision of the future, most people would live in outer space and Earth would remain as a sort of national park for them to visit on occasion, which is utterly inhuman and horrific to most normal people. But it just basically went without comment. A few people were like, oh my God, that sounds horrible. This billionaire is talking about putting us on space ghettos and keeping Earth for themselves. Well, I mean, that's our guy right there, right? And so the whole thing with Blue Origin with a penis-shaped rocket and the Amazon smile with a penis-shaped smile, I think it does in many ways represent the kind of masculine underpinning of transhumanism in the entire kind of technological endeavor. But also, he's invested in Altos Labs in conjunction with Yuri Milner. And Yuri Milner is much more openly transhumanist. He wrote a manifesto, I can't remember the name of it, talking about human life, giving away to Silicon Life. But Altos Labs is dedicated to human longevity through genetic engineering. Peter Thiel also involved in this. Obviously Bill Gates involved in this. Most of these, Larry Page and Sergey Brin at Google also involved in this. Very, very, very popular among the billionaires. [32:41] But as you mentioned, Amazon one. Here you're talking about really this kind of pop beast system, wherein Amazon customers, now Panera Bread customers, also Whole Foods customers using their palm biometrics in order to pay for things and identify themselves. I think that that is going to be a much more popular way of implementing what Christians would call a beast system because a lot of people fetishistically implant RFID chips for that purpose. That is really unnerving to a lot of people. Whereas if you take that away entirely and just have a biometric scan, it's much more amenable to the general population. I don't know what the numbers are yet for the customers, but I do know that it's many dozens of stores this is rolled out in so people are using it. Moving over to the right though, you've got Elon Musk who is everything but an open transhumanist, right? He he espouses all of the transhumanist values without ever using the term transhumanism It's very very common ploy, right? So everything from the idea that artificial intelligence will achieve this godlike state to, the only way that human beings will be able to survive in such an environment is to link our brains to it to friendly AIs through an invasive brain computer interface, which he's working on. [34:04] He's also working on artificial general intelligence with Tesla AI and one would imagine that, he has and will be using Twitter data for the same purpose, right? He didn't need to buy Twitter for that, just by the way. Twitter has always offered Firehose API for people who want to data mine Twitter. The only thing that really gives you is 24-7 fire hose access and also access to the DMs other than that a lot of people are training their a eyes on Twitter or have been, [34:36] interestingly musk has cut that off anyway, and then also you know musk and his obsession with going and living in space This is a recurring theme of transhumanist to get off of Earth and become the sort of multi planetary, species and The creation of the robot optimist would be another great example example, the rollout of autonomous vehicles is another great example. I mean, at that point you've got an infrastructure that controls you as much as you control it or maybe more. And so it's really interesting this way in which he's captured the hearts of the right, mainly because he's cool, he's funny, and he at the moment is so anti-PC or anti-woke that there is a certain alignment there. And I appreciate all he's done in that direction, but to me, his long-term vision of the future is more important than the short-term favors he might have to offer. And then moving to the farthest right, Peter Thiel, much more openly involved with these different transhumanist movements. [35:42] What is it called? The Methuselah Foundation, he's invested in heavily. A number of other sort of longevity start-ups he's invested in. He was very interested in Ambrosia, which was, was they've shut down operations now because of threats from the FDA. But Ambrosia is a process. They use the process of parabiosis. They would inject young people's blood into older people to give them more vitality. And of course, Peter Thiel founded Palantir. [36:13] Which even if they're not working on artificial general intelligence, their AI systems are among the most sophisticated in the world. And they're used to, uh, to really apply real world power through the military and through the security state in general. And so on and on, again, as I mentioned, Peter Thiel was an investor in, originally investor, an investor in Neuralink, now a major backer of BlackRock Neurotech brain computer interfaces. So, you know, across the spectrum, one last thing, actually, if I may, One last thing about Peter Thiel that's also really interesting. Of all those people I just mentioned, he is also explicitly religious in his outlook. And so Peter Thiel is oftentimes written about Christianity and the relationship it has with technology. And maybe the most important essay that I'm aware of personally is an essay that was published at First Things, Christian magazine, the title being Against Edenism. [37:21] And in that he argues there's no going back to Eden of Genesis, there's only going forward to the city of God in Revelation. And so Christians need to use these technologies to defend, to bolster and defend their civilizations, to create a sort of kingdom of God on Earth or some approximation of the city of God on earth, and city of heaven on earth. [37:50] To me, I think that it's a kind of gross perversion of what the Christian doctrine is. I mean, not that there's any single Christian doctrine. I know many of your religious listeners might take umbrage with that statement, but the sort of general orientation of Christianity is towards a higher spiritual realm and is at least disinterested in the outcomes of the physical body, this technological obsession is obsessed with physical outcomes. So Thiel is also interested in that way. Aside from funding all these kind of Christian Republican candidates, he also uses Christian mythology in order to push a kind of technocratic or transhumanist point of view. Can I pick some of the names? The whole chat-GBT thing. I know Peter Thiel and Elon Musk were involved in the beginning and then Microsoft came along and put in billions and seemed to have taken that partially as their own and then the whole letter from 1800 opposing, the move of AI in general. But I mean I'm Gen X so it did take my older son to show me the South Park episode about chatGBT and then I thought I have to get up to get up to speed. But I guess people just see that as [39:20] helping society, making your life easier. It doesn't seem too invasive. It's just [39:27] for lazy people, they can use that. And how does that kind of fit in? Because chat GPT has been very much in the media recently. ChatGPG set off a social atom bomb. It's just really insane. On the one side you have all these people who have embraced it. On the war room we've really focused on guys like Hans Monk at Epic Times who is very enthusiastic about it as being a way to break the left. And then of course Jordan Peterson. People really got mad at me, but he does sound like a real wiener when he's talking about it being smarter than you are. Are and oh Elon Musk is going to save us. Sorry for your Jordan Peterson fans but I find him to be very off-putting. Anyway, they talk about it as kind of this god-like entity in some sense. And then on the other side, which is really, really interesting, on the other side you've got guys like Eliezer Yudkowsky and Elon Musk and Yuval Harari and Max Tegmark. All of them, transhumanist basically, with the exception of maybe Harari. I know a lot of people would wonder why I would say that, but I don't see him as being a transhumanist in any meaningful way. Anyway, all of these transhumanists are saying that this represents a profound danger to human civilization. So why would they say that? It's a chatbot. It's nothing but a chatbot, right? [40:55] And the real reason, there's two major reasons, right? One, the unexpected capacities that GPT technology, has exhibited, the sort of general knowledge that it's able to put out on the basis of, you know, nothing more than a neural network, right? Like you're just talking about an artificial brain that exists in a virtual system, but because of its size and the scale of the data it was trained on, it surprised everyone. GPT-3 surprised everyone. GPT-3.5 or chat GPT really surprised everyone as they flooded the public with it and people started having these very, personal interactions with an artificial mind and that was really important before they put on the safety layers people oftentimes say oh AI is just woke, Initially it wasn't just woke before they started putting the safety layers on it. It was actually [42:03] unbiased hence the enthusiasm that people like Hans Monk and Jordan Peterson had for it and [42:09] GPT-4 has really stunned people because it's starting to edge towards general intelligence. And just, I've been speaking about it, but just for any listeners who aren't familiar, artificial narrow intelligence is an AI that can do one single task or one kind of narrow range of tasks, such as play chess or go or play video games or control a microchip production system or to spit out words like chat GPT, right? Artificial general intelligence is something more human-like in which you have multiple cognitive modules that thinks across all of these domains and oftentimes simultaneously. Doesn't exist yet, but GPT-4 represented a huge move in that direction. It was able to translate, for instance, vision into text and make reasonable conclusions about it. It was able to solve mazes, right? It's a language model, it was able to solve mazes. And maybe most importantly, it excelled on human testing. [43:18] So the two most impressive were the GRE verbal test, 99th percentile was its score. And then you've got the US Biology Olympiad, again, 99th percentile. And then you had the LSAT and the bar exam, law exams. And that was 90th percentile and 88th percentile, respectively. So [43:46] people saw this as this incredible potential. Where is it going to go next? That's the fear. Now I personally am quite stunned that people are so enamored by this and that they want to embrace it. I think the biggest danger that this technology poses is that people like Bill Gates, right? Because Microsoft backed OpenAI, They're incorporating all of these GPT technologies into their systems. And so Bill Gates is talking about using it for education. A lot of people are talking about using it for education, meaning that education will become more and more, more than it is now, e-learning, digital learning. And these students, the youngest generation is going to develop this human AI relationship that is going to stick with them for life. And transhumanists oftentimes talk about how in an ideal future, you would have your own kind of personal AI as a type of guardian angel that would teach you about the world and would learn you better than you know yourself, right? And give you the advice that you need to get through life. You're talking about the most powerful brainwashing technology ever created. [45:05] And, you know, aside from that, you've got all of these different jobs that are being obliterated, everything from copywriters to editors to lawyers and even doctors and nurses. So that is, again, you're talking about the digital mediation between humans and all these kind of critical services. Maybe most importantly, preachers, rabbis, imams, I assume, using these technologies, specifically chat GPT, to create their sermons or to read, you know, to maybe a more autonomous system, just a simpler system to read liturgy. This is already occurring in like small little points across the planet. It has not yet taken off. But I could definitely foresee a future, especially after all of these children have been brainwashed by this technology, in which as you and I get old and die, literally, we've got a robot standing over us, reading us our last rites, as our, you know, the contents of our consciousness are made manifest through some sort of digital zombie made from all of our data. I mean, it sounds sci-fi, but barring nuclear war or an EMP, something like that is going to happen in certain societies around the world. So the big danger I see are those more immediate dangers, the psychological danger and the sociological and economic dangers. But you've got guys like Eliezer Yudkowsky. [46:33] Who say that, Nick Bostrom is also a major figure, who says that this represents a move towards an artificial general intelligence that is not aligned to human values, and it's not necessarily aligned to human existence. And so if the next iteration in GPT-5, or the next iteration in GPT-6, or any of these other AI companies that are working in competition with them, or any of the militaries around the world who are developing other artificial intelligence systems, if any of these create a digital brain that is large enough and fast enough and astute enough, I guess is a way of putting it, then you end up in a situation where you might get a hard takeoff, right? An intelligence explosion, what Nick Bostrom calls a super intelligence. And if that super intelligence is not aligned to human values or does not regard human existence as being necessary or desirable then it could easily take control of [47:42] critical infrastructure it could take control of weapon systems It could take control of a biolab or a series of biolabs, Or it could take control of individuals within a society to use any of these critical systems in order to destroy some other people or all of humanity. That's the fear that Eliezer Yudkowsky is talking about and it's entirely based on all of these kind of emergent properties from a chatbot that should just be you know some sort of rote memorization sort of regurgitation of all this knowledge but instead is showing this flexibility. The fear is that chatbot or maybe it's a robotic system or maybe it's a military simulation system or maybe it's a military control system. It could be any type of AI But if it reaches a super intelligent state, The fear is from their side that it would obliterate some or all of humankind, again I think it's very very important to listen to just for this for the same reason that all the warnings about the atom bomb were were very, very important to listen to. But in some ways that distracts from the more immediate and certainly attainable goals of rolling out these AIs across the society and using them for social control, for indoctrination and for mass surveillance. [49:06] I just wanna, I'm looking at time, but just wanted to bring in one final post that you had put up. This is on your GETTR and this was a YouGov America. I just want to touch on just for a few minutes, because it's interesting to see what the public rise. It was interesting, actually, YouGov, asking the question, how concerned at all are you about the possibility that AI will not just have a negative effect, but will cause the end of the human race on Earth? So it was a very hyperbolic question. But on this, you had 19% very concerned, 27% somewhat. So you've got 46% are concerned, 13% not knowing. So it seemed very evenly split. Half the people who were asked either were concerned or didn't know what it was about or unconcerned and didn't know. That was not only the type of question asked, that was intriguing, but the response was also intriguing. What were your thoughts when you posted this? I think it was back on 5th of April or so when you posted this. Well, it's obviously is an expression of that open letter that was put out by the Future of Life Institute calling for a six-month moratorium [50:19] on any AI above the level of GPT-4. Then, of course, Eliezer Yudkowsky published the now famous, op-ed in Time Magazine saying that's not enough and that all large GPU clusters, all large AI training centres, data centres should be banned. And if intelligence is aware of a training center working on a massive AI system, a potentially super intelligent system, airstrike should be on the table even at the risk of nuclear war. So this has flooded the national consciousness here in America and I presume world consciousness across the globe. I've been very provincial of late, so you'd have to tell me. But I know that just regarding that poll, which is an American poll. [51:15] This is flooding people's consciousness. It's always been there, latent consciousness has always been there in science fiction, everything from the Terminator and things like HAL 9000, all these sorts of motifs have always been there. Now, it represents a distinct possibility in people's minds. But that 50-50 split that you're seeing there, roughly 50-50, half and half, what's interesting is that give or take 10, 15%, either direction, on a score of issues, that's what you see in the American psyche. So you saw during COVID, I would say roughly half of the population became, you know, COVIDians and wanted to mask up obsessively. The other half, even among those who complied, really weren't into it. And on the extreme end, which I would place myself, were fiercely opposed and furious about it. [52:14] Same thing, basically, basically enthusiasm for the Vax. I don't know of any hard statistics. Forgive me if I'm a little wrong, but basically you've got this split, a significant enough split that each side has some potential of taking over the federal government and applying their will on the other half. Well, another really interesting poll that was done by two researchers, led by two researchers from Harvard and I believe Cambridge, if I'm not mistaken, looking at the Americans, and they surveyed asking them, if your child would have a better chance of getting into a top 100 college, Would you be willing to one, edit the embryo's genes to give it higher intelligence, or to use a polygenic risk score, or the pre-implantation testing, genetic testing, to figure out whether or not the IQ was high enough. [53:14] To give your infant a better chance of having a high IQ. And so, about a third, and this is roughly the same roughly the same for uneducated or more educated, skewed towards more educated, skewed towards younger, about a third, almost 40% among educated said they would be willing to edit their embryos genome [53:38] in order to give a higher IQ, just under half, just under 50% for the polygenic risk score. And what that means is that you conceive the child in vitro, right? Right the test tube baby from the 1970s you conceive the child in vitro and then you freeze the embryo and what you really do is you you stimulate the ovaries to produce multiple eggs so you end up with around 10 to 15 eggs and you conceive all of these and then you freeze them after taking a sample of the cells you do a polygenic risk or you do genetic testing on all of them and I've described this as being somewhere between a basketball tournament and a spelling bee basically you, one that is deemed to be most likely to be smartest also tallest and certainly devoid of any major, deformities or genetic diseases that one gets picked that one gets implanted either in the mother or as it's become more popular a surrogate and [54:44] then you have this kind of slow rolling process of eugenics This is already being done. And one of the major companies is Genomic, what is it, I believe it's Genomic Prediction, if I have the name right. And that was a startup funded by our boy Sam Altman from OpenAI, and they offer a sophisticated polygenic risk score test that includes IQ. It doesn't include positive IQ scores, but what it can weed out is the lowest 2% in IQ, or the lowest 2% in height is one of the things they offer, right? And so you've got this sort of soft eugenics, what's called liberal eugenics by the scholar Nicholas Agar. But liberal eugenics is not state enforced, it's choice, it's freedom, right? I have the freedom to eugenicize my child and the next generation. So looking at those statistics, you see the significant portion of the population that has enthusiasm for it. And that tracks with a previous poll that was published, I believe, last year from Pew, which found that people, it was like roughly a third, if I'm not mistaken, roughly a third of people would be willing to use genetic engineering [56:06] to eliminate a disease. And some other, I believe it was also roughly a third, said that they would be willing to implant a digital device into their child's brain in order to give them increased intelligence. I'm a little fuzzy, it's been a minute since I've looked at that, but it's significant enough to push this forward. And you have the possibility of it, right? You have the technological possibility of it. Some of it just over the horizon, some of it right here. So going back to the idea, well, is AI going to kill us all? I think it's you know it represents the the people who are going to want to put a halt to AI and the people who are at least going to want to regulate it or to boycott any corporation working on it those are going to fall into that half that cares right that half is afraid the other half is going to be much more likely to either not care and dismiss it or perhaps be enthusiastic about it with a lot of overlap, but this is kind of I'm not much of a futurist look at any of my track records for girlfriends gambling or elections, but I [57:21] do think that what you do see is enough social momentum enough acceptance on the part of the population at large large that should these technologies actually be effective, you'll have a significant proportion who will want it. And even if they aren't entirely effective, even if it's just some sort of half-baked version of it, they will be willing to accept and adopt it. And so I don't see this going away at all. Again, barring nuclear war or an EMP, I just don't see it going away, there is a growing enthusiasm for the techno cult we call transhumanism and a growing acceptance of the kind of dictatorial social structure we call technocracy. And I sense that it is a fast-growing religion, and it will continue to impact those of us who want nothing to do with it. We have to learn to deal with it. We have to learn how to resist it effectively and and not just this year and next year, but across generations. [58:27] Yeah, no, absolutely. Joe, I appreciate you coming on. I've thoroughly enjoyed watching you on the War Room. I enjoyed meeting up with you at CPAC. And just for the viewers that they can find you, this will be going out Monday the 17th, the American Freedom Alliance Conference. I had the privilege of going to one back in June called Propaganda, and you'll be speaking at the World War III, the early years, 22nd to 23rd of April. So there are tickets available. You can go to the website, americanfreedomalliance.org and get a ticket. If you're over there on the West Coast, then I would really encourage the viewers or listeners to go and make it a trip because you'll thoroughly enjoy it from listening to Steve Bannon, Joe Allen, and everyone else in between. So Joe, thank you for your time today. Thank you very much, Peter. And just for your listeners, anyone who wants to go, promo code Joe, get a discount. So I would love to meet anyone who's over in that area. Come on down. But yeah, Peter, I really, really appreciate it. Thank you very much for having me on. It was absolute, it was fantastic meeting you in DC. Great time, hope to see you again.

Our very first guest, JoJo Platt, is a longtime consultant serving the neurotech community through the commercialization process. In this episode, JoJo discusses her eclectic background, views on leadership, the future of neurotech, and how good-natured "revenge" is one of her primary motivators.  Guest links: http://theplattassociates.com/ | https://www.joyventures.com/ | https://neurotechreports.com/ | https://skrapspodcast.com/  Charity supported: Polaris Project  Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editor: Tim Oliphant Producer: Velentium   SHOW TRANSCRIPT Episode 002 - JoJo Platt Lindsey Dinneen: Hi, I'm Lindsey with Velentium and I'm talking with MedTech industry leaders on how they change lives for a better world. Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome to the Leading Difference Podcast. I'm your host, Lindsey, and I'm excited to introduce you to my guest today, Jojo Platt. Jojo is a longtime consultant serving the neurotech community through the commercialization process. She works with academic labs, neurotech startups, and others to advance neuro technologies into the hands of patients. Jojo is the US Partnership's lead for Joy Ventures. She works with Neurotech Reports, co-hosts the Skraps podcast, and serves on many organizing committees of the industry's most influential conferences and meetings. And I am so thrilled that she is joining me today. Welcome to the show, Jojo. Thanks for being here. JoJo Platt: Thank you for having me on. I'm really excited to be on the other side of the mic this time. Lindsey Dinneen: Oh yes, that's right. Please tell us a little bit about yourself and your background to get started, if you don't mind. JoJo Platt: Sure. I work specifically in the field of neurotechnology that's even more narrow than medical devices. I prefer to think of it as a different focus than just pure, broad speaking neuromodulation and I've been consulting to academic labs, startups, government offices, universities, kind of everybody in the neurotech space for about 15 years now, and a lot of people find it challenging to really fully understand what I do. So I keep it broad because I do a lot of different things. I like to think about all of the scientists and technologists who have spent their entire lives honing and perfecting their science and technology skills. And I come in on the other side of that and help them on the business side. So if they're ready to translate, if they're thinking about creating a spin out, if they wanna optimize their research for future licensing and spin out, there are things that can be done even at the academic level that can make a big difference into how technology or therapy commercialized. And I do everything except for accounting and housekeeping. Lindsey Dinneen: Amazing. So I am curious, do you mind delving a little bit more into how you help bridge the gap between a company or an individual who is looking to develop new technology? And what have you found is the most needed aspect of that sort of bridging the gap process or how do you feel that your consulting and your services are able to help these people? Because I know you're making a difference, but I'm curious as to what things you find are the most common, and where people can use that assistance from a different perspective? JoJo Platt: The field overall, especially the commercialization side of the equation is still relatively young. I know, spinal cord stimulators coming out Tom Mortimer's lab and all of that in the sixties and some of the cardiac pacemaker technologies, those have been around for a long time. But when you get into some of the neural interfaces, be it in the central or peripheral nervous system, those are on the newer side. So we still have a lot of technology founders or technical founders, or scientific founders, which is fantastic. There's nobody who knows the technology and the science better than these folks. But like I said before, they're classically trained on the science and technology side of things. So there are tons of resources out there that can help prepare them to be a CEO or a founding CEO. But they still need a lot of support and whether they find that they need help in making their business case as they're pitching for financing to VCs, helping them hone that pitch, whether it's in support of market research, helping them determine what's the best path to market sometimes. I primarily like to focus on FDA cleared or FDA approved devices and I definitely favor implanted devices over wearables, but there are definitely fantastic wearable technologies. That's all to say that direct to consumer is something I can appreciate and admire, but that's not an area of expertise for me. So I'll help them look at the regulatory pathways, reimbursement pathways. I either do that on my own or I also work very heavily with a team at Neurotech Reports, Jim Cavouto and Jeremy Koff, who both have excellent track records in Neurotech as well. Lindsey Dinneen: Yeah. That is wonderful. And so when you are helping these folks, these scientists-- I think we talked in a previous conversation about how sometimes the business aspect, like you said, you can learn a lot about how to be a CEO and there are certain things that maybe come a little bit easier than others, but in terms of, say the marketing side of things or how to translate the science into a more widely understood-- if you're going to explain it to your grandma kind of thing. You have a really interesting background that didn't necessarily start in the science field. Do you mind exploring a little bit about how that helps you translate between the two? JoJo Platt: Sure. I have a very long sort of meandering journey into a lot of different areas. I started out my first, I like to call it my first real job, my first office job was a one person of a two person accounting team at an internet backbone technology company. And that's to say, because this was in the mid to late nineties, it wasn't part of the dot com boom so much as it was, anytime you watch video on the internet, that call and response of the video packets that get delivered to you are still done even now, 25 years later on the internet backbone which is video delivery optimization. So we were basically solving how to stream video on the internet when the internet was operating at basically a 14 4k speed. So accounting, I thought that's what I wanted to do. That was my degree program at the time, and I was in school and working and being a single mom and all that. And we went through an IPO, which was an amazing learning experience, but it was a lot of work. I'd go to the office at six in the morning. Work till six at night. Go to class, go home, see my daughter, go back to work until about two o'clock in the morning and they go back at six and it burned me out. We were a startup and the hours were long, so, after the IPO I was processing some expense accounts and I kept seeing all of these marketing expense reports come in. I'm like, "you guys went to dinner where? You spent what? You did?" And I'm just like, "wait, let me get this straight: you're having this much fun and I'm sitting here behind a desk processing your expense reports." So I said, "this is over. I'm going over to marketing." And so I was still in school, so I changed my major and finished that up on the comm side of things. I don't tend to refer to what I do now as marketing or communications. Because it's only a part of what I do, and also because those words tend to scare a lot of scientists. They don't believe in self-promotion. And they just find the marketing and communication side of things, PR and that sort of thing, quite unsavory. So I don't talk about it in those terms, but that is a little bit about what I do and especially, my own, I guess you'd call it a brand. I don't know that it's brand so much, but it just happened. So yeah, from accounting to marketing, I went through the dot com bubble in the early two thousands with the community site that was the early competitor to MySpace and earlier than Facebook even. So we raised a lot of money. The founders burned through all of it. That crashed. I decided at one point I was gonna kinda have an early retirement 'cause I had done well with my IPO and then got bored. I've done consumer electronics, was working with a technology company trying to solve the whole Napster problem with copyright protection for music. And we were a finalist in the industry competition that was gonna lead to an industry standard of content protection. And then just a month or so before it was all finalized, iTunes came out with a 99 cents song, which between the lawsuit against Napster and an affordable easy, one click way to get music, that pretty well solved the problem for the most part. So that one went away.  then from there I ended up, this one's a really strange one. From there I ended up going and working at a nonprofit that had, before my arrival, they had fallen afoul with the IRS and it wasn't-- the nonprofit needed some closer management. For the most part it was doing okay. It was doing what it was supposed to be doing. For, again, for the most part, its problem was that the founder was a person of interest in his other business dealings. So IRS and the Department of Justice figured they were gonna "Capone" this guy. Basically go after him and get him for anything that they could, whether it was directly related to the insurance schemes that he was running or if they could get him some other way. So I jumped in, became the court appointed trustee for the foundation and helped the DOJ and the IRS Criminal Investigations Division actually put this guy in jail. So that was kind of, it was a little scary at times. But it was fun. And at the end of the day, I got to help give away 47 million dollars to a lot of different charities. And one of the things that we wanted to look at was sepsis research, because one of our board members, his daughter passed away very quickly and very unexpectedly from sepsis. So we wanted to support sepsis research. And found out that Kevin Tracy at the Feinstein Institute in New York was doing a lot of really exciting work in sepsis and I started helping them out on a consulting basis on some of the sepsis activities and then some Parkinson's research initiatives that they were working on. And as they were getting ready to launch the Center for Bioelectronic Medicine, they just kept pulling me on board for project after project and kept consulting on that helped them launch the center with some very good friends of mine. I'm glad to say it's still a very successful research entity and putting out amazing work. And we launched a journal by the same name. And part of my responsibilities there were to really understand and know the players in the field of neurotechnology and find out what they were working on and see if I couldn't help to facilitate collaborations, whether it was research or further down the road into the commercialization spectrum. And that's how I fell into neurotech. It's a very long, very circuitous, bumpy road. Lindsey Dinneen: Yes. But it's an amazing backstory and it has led you to a whole new chapter really, and new opportunities that you probably couldn't have imagined when you first were even in school. Thinking ahead, what's my life gonna look like? So that's... JoJo Platt: I'm still waiting to find out what it is I'm gonna do. Lindsey Dinneen: That's amazing. Yeah. Well, I'm curious, is there a particular moment that stands out to you because it clearly confirmed that this chapter was the right next step for you? I know you had mentioned the importance of working on the sepsis research and supporting that initiative and things like that. Obviously that was something that was important to you, but I'm curious, as you've continued along this path, is there just something that stands out where you thought, "yes, this is the right next chapter for me" and why? JoJo Platt: I don't think there was a single moment. I think somebody asked me a similar question at a conference earlier, I guess last fall, and, "Why are you doing this?" And, "What got you involved or what keeps you here?" And I think part of it is still really true. That part of it is revenge. Don't get me wrong, I went to a very excellent high school, but my science teachers saw in me a very, very strong lack of scientific ability. I didn't apply myself in my science classes and they all begged me never to take a science class again-- just get through this one and don't take any more science than is required. So I think the part that keeps me here most is that I'm not a scientist and I'm not a technologist. I've definitely learned a lot from everyone that I've had the good fortune of working with or seeing some of the amazing talks that I've seen over the last 15 years. But I can have an impact and not be a scientist or a technologist. And I think that inspiration keeps me going. And I'll be on stage with some of the world's most important neurotechnologists, and I always make sure and take a picture and then send it back to my science teachers and say, "See, I did okay". Lindsey Dinneen: I love it. JoJo Platt: Yeah. There might be a little spite there, but just, all good fun. Lindsey Dinneen: Good natured. JoJo Platt: Yes. Yes. Lindsey Dinneen: That is seriously amazing. I definitely have a little bit-- I'll put it this way-- I have enough rebel in me where if someone says that I can't do something, then I have to prove them wrong. JoJo Platt: Right. Lindsey Dinneen: It's just -- we're gonna figure out how to do this, might not come easily, but we'll figure it out. JoJo Platt: Yeah. And I don't think I would've gone out of my way to do that had I not stumbled into this field, but the fact that I'm here now, I'll leverage that a little bit. Lindsey Dinneen: Yeah. Yeah. Amazing. Well, how would you define leadership? Or what does leadership mean to you? JoJo Platt: To me leadership is not so much telling people what to do, but making sure that your team is inspired to follow you. And I think that difference is one thing that's really important between a boss and a leader. Also why I don't have employees. I think that bringing on the right team members for the right problems and empowering them to do their jobs is probably, a pretty inspiring leadership principle. And the people who have that gift are people toward whom I gravitate, just sort of in, in my own personal fandom of that capacity. And when I see that I like to highlight that and foster that. But I think I know my own weaknesses, which are anything in the area where HR would have jurisdiction, I'm the worst nightmare. And I love being a collaborator, but being a leader is a gift that I think I'll let others take the helm for that one. Lindsey Dinneen: Oh, that is fair. I appreciate that perspective. Well, what is your best piece of advice for someone interested in obtaining either a leadership role within the med tech industry, or since you talked about being in more of a collaboration role or a collaborator role, what is your best piece of advice if someone's looking to do something similar to what you do in helping bridge this gap in helping assist these amazing people bring their ideas to reality? JoJo Platt: I think one of the greatest parts about the neurotech field is that we're still young enough that there are opportunities everywhere, and I know we're going into a bit of a shrinking right-sizing economic exercise, and that some of that will include some painful moments for a lot of people. But I think from my experience, it's better to correct than to crash. So I'm optimistic about where we are in that, and I think that we are truly at the point in the field where there's a legitimate reason to say, if your dream job in neurotechnology doesn't exist, go and create it. And I think this space is open to so many different areas of expertise. So we need people in finance and business management, administration, operations, systems management. And yes, marketing is actually starting to become a legitimate and respected division of a lot of different companies. So that's good to see. But you can really come from any field and contribute to neurotechnology. And one of the things that I see a lot are people who have a hybrid blend of expertise. So they might be neuroscientists by training who went through an MBA program or an MBA candidate who has strong engineering background. Those are the kinds of cross talented people that we're really gonna need. And I think we are seeing a lot more interest from the sort of traditional business categories of contributors to the point of we need more qualified CEOs in our field, and we need more people in finance that really understand what the technology implications are. A lot of my clients really are focused on and need regulatory and reimbursement experts. There's a need for people who have organizing backgrounds. For instance, next week in DC, Paradromics has been instrumental in putting together our BCI days going to talk on Capitol Hill about export controls on brain computer interfaces so that sort of organization and lobby expertise. So I think that if you have a passion in terms of what it is you want to do and you want to apply it to the field of neurotechnology, there are so many opportunities that didn't even exist even 24 months ago. So I think we're growing quickly and it's exciting to bring new people into the field and help accelerate and propel these fascinating and really potentially hugely impactful technologies. Lindsey Dinneen: Yeah. What do you see as being some of the most exciting trends in this field moving forward? JoJo Platt: Well, brain computer interface is definitely one. There are some really great players in the field. BlackRock Neurotech has been the leader in the field and out of the, I think we're-- I think we're right around 40 or 40 plus humans who have been implanted with brain computer interfaces. And well over 30 of those people have BlackRock technology implanted. But we're seeing some really great newcomers with novel ideas, novel technologies. Paradromics, who I previously mentioned, is one and Synchron has been getting a lot of attention for their vascular approach to a BCI. Precision Neuroscience just closed a big round last week. And Motif Neurotech is exciting. That's a new technology out of Rice and it's a minimally invasive brain computer interface. And their first indication is major depressive disorder. Inner Cosmos is going after the same indication with their minimally invasive approach. They're both exciting to watch. And I think BCI obviously gets so much more attention because of Elon Musk's involvement in the field. Lindsey Dinneen: Yeah. Well, I am excited to also continue to learn about the new developments coming up. It is a crazy time. I joke about this a lot, " what a time to be alive." But seriously, it is so exciting to see what's coming up, what's possible these days just is amazing. It's mind blowing. So thank you for sharing some of your insights with that. JoJo Platt: My pleasure. It's a fine line. You wanna talk about the potential, but you also have to be reasonable in managing expectations, especially with a patient population that needs the therapy. Promising and underdelivering is something that everybody is very focused on maintaining that integrity. There was a talk couple weeks ago where the CFO of BlackRock Neurotech said, "we like to focus on the "art of the possible" and being sure that we're not over representing what is today possible and what will may eventually become possible." And I like that. That to me, is very responsible communications. Lindsey Dinneen: Yeah, absolutely. So I'm curious, how do you prioritize your continued learning and growing as a leader, as someone of influence within your industry. How do you prioritize your continued growth? JoJo Platt: I've just been so lucky to meet and engage with so many really exciting researchers, whether they're on the science or technology side. And I'm at the point where a lot of what comes in front of me, people will send to me directly and they're like, "Hey, Jojo, this just came out." Or, "this is a publication that's coming out next week. Let's see if we can amplify it." So a lot of my sort of choices are spoon fed to me. And then that sends me down a rabbit hole. I mean, there's so much to discover. Anywhere you look it's out there. So I should be more strategic about it. If you have something that you think is really important that you think the community wants to know about, I do invite people to send it to me. And if I have a chance to amplify it and call attention to it in any small way, then I'm grateful for that opportunity. It helps me see different things that I might not otherwise. Lindsey Dinneen: Yeah. Well, and that's a great segue into, I'd love to learn a little bit about your podcast. Is that one of the tools that you use to amplify some of those things? Or is that completely separate? JoJo Platt: It's a little bit of both, so. Okay. The podcast is scraps with a "K," S-K-R-A-P-S, and that's because a lot of scientific exploration and inspiration comes at the bar talking to your colleagues and you write your idea on the back of a scrap of piece of paper. And the other reason it's called Skraps is cuz it's "spark" spelled backwards. Anyhow, my co-host for that is Arun Sridhar and he's the former head of Discovery at Galvani Bioelectronics. So he brings the scientific rigor to the podcast and I'm the cheeky monkey who gets to be a little sillier. But we've done a little bit of everything. It is a hobby for us and we like to highlight people that have inspired us in different ways. But we also are sure to try and make it fun. So we've done everything from human composting. Shortly after Covid hit, we had the graphic artist who did the rendering of the Covid molecule, the gray ball with the spikes that is everywhere, which was a fascinating story. She literally got woken up outta bed in the middle of the night in January 2020 and they said, "We've got something, you've gotta come down here and draw this for us." So that's an interesting thing. Okay? So I'm like, "You wanna just put me on speed dial next time you get one of those calls and tell me about it?" But we've done everything. They're incredible leaders in, in science and research. On the show we did a 10 part series on psychedelics in research. That was about a year and a half ago now. So that was at the vanguard of the psychedelic research revolution. So we did a pretty comprehensive history back to early human use all the way through the obvious fifties, sixties, seventies with MK Ultra and then what's happening in research today and how some of the people who are benefiting from psychedelics and psychedelic therapy. And then now we're in the middle of a series on the vagus nerve in neurotechnology. So we just do a little bit of everything, whether it's a topic or a person or a personality. We try and keep it fun. Lindsey Dinneen: I love that. That's awesome. Okay, well, for fun, imagine someone offered you a million dollars to teach a masterclass on anything you want-- doesn't have to even be in your industry. What would you choose to teach and why? JoJo Platt: Oh, that's a good one. I don't know that I would be qualified for that. I've always thought of myself more of a jack of all trades, master of none . I'm a boy scout. I'm prepared for anything, but I'm maybe not the master at any one thing. And I think that's what I love about so many of the people that I encounter, is that they've dedicated their whole educational career, their professional career to one particular thing and they can teach the master classes and I'll sit back and watch and then post about it. Lindsey Dinneen: What a fun answer. Okay. Well, do you think you could then teach a masterclass on how to be prepared for anything because you never know what will come your way? JoJo Platt: I do have my shortcuts, like when I really get in over my head with a neuroscientist, I can start talking about engineering, and same thing if I get in over my head in an engineering conversation, I'll switch over to neuroscience or something. And if I get really flustered, I'll just say "The mitochondria is the powerhouse of the cell!" and walk away. Lindsey Dinneen: Brilliant. JoJo Platt: So yeah, you always wanna have a couple catchphrases that'll get you into or out of any conversation. Lindsey Dinneen: All right. I like it. Yeah. I need to develop a few more of those, I think. What is the one thing you wish to be remembered for after you leave this world? JoJo Platt: I hope that when I'm gone that the people that I've known and had the privilege of being associated with, either professionally or personally, oftentimes both-- that they always knew that I was there if they needed help or if there was some way that I could contribute to their success, that would be the greatest highlight of my day. I'm not the one doing the hard stuff, so I'm here to help the people who are, and if that's how I'm remembered, I wouldn't hate that. Lindsey Dinneen: Yeah. I love that. Well, final question. What's one thing that makes you smile every time you see or think about it? JoJo Platt: But one of the things that, I find wonderful, full of wonder, fill me with wonder, are really the pieces of science that you don't realize, or mathematics or engineering that are all around you all the time, and if you know where to look or how to find them, you start to see. I have a fascination with Fibonaccis. So if you start to read and learn about the Fibonacci Sequence and how it's applied and where it's found in nature, where it applies in mathematics, how it affects what we view as aesthetically pleasing-- there's "The Great Wave of Kanagawa," which is a Fibonacci Sequence. It's an old Japanese block print that is perfectly aligned with the Fibonacci spiral. So things like that. Things that blur the line between mathematics and science and beauty. I think that's pretty inspiring. That makes me smile. Lindsey Dinneen: Oh, I love that. That's beautiful. Well, I just wanted to say thank you so much for joining us. Thank you for sharing about your background and all the fascinating things that you have done that have led you to where you are right now. And who knows what you're gonna do in the future, but it is so fun to hear about it. So thank you for being so open sharing all those wonderful things. And we are honored to be making a donation on your behalf as a thank you for your time today. It's going to Polaris Project, which was Jojo's choice, and that is a non-governmental organization that works to combat and prevent sex and labor trafficking in North America. So thank you for that, Jojo. Thank you so much again for your time. We wish you just the most continued success as you work to change lives for a better world. JoJo Platt: Thank you. Thanks for having me on. I really appreciate it. Lindsey Dinneen: Of course. And thank you also to our listeners for tuning in, and if you're feeling as inspired as I am right now, I'd love it if you'd share this episode with a colleague or two, and we will catch you next time.  The Leading Difference podcast is brought to you by Velentium. Velentium is a contract design and manufacturing firm specializing in the development, production and post-market support of diagnostic and therapeutic active medical devices, including implantables and wearables for neuromodulation and other class three indications. Velentium's core competencies include electrical design, mechanical design, embedded software, mobile apps, contract manufacturing, embedded cybersecurity, OT cybersecurity, systems engineering, human factors and usability, and automated test systems. Velentium works with clients worldwide from startups seeking seed funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedIn. Episode Title:-

The ability to control machines with just our minds is the well-worn stuff of science fiction. But science and engineering advances in brain-computer interfaces (BCIs) have rapidly brought these fantastical ideas into the realm of science fact, with remarkable implications—allowing, for instance, paralysed patients to regain control of their limbs and communicate just by thinking. In this week's episode, we ask whether we're at a turning point for BCIs, explore what the next decade looks like for medical and consumer applications, and how we can responsibly shape the technology's development. Featuring Ian Burkhart, BCI pioneer, Florian Solzbacher, co-founder of Blackrock Neurotech, Rajesh Rao, professor of computer science at the University of Washington, and Nicholas Opie, founder of Synchron.This episode is sponsored by Pictet Wealth Management and includes additional commentary from Adrien Brossard, senior healthcare analyst. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we talk with medtech vet Matt Franklin who left the industry. – sort of – to help lead Akili, developer of EndeavoRx, the first prescription treatment delivered through a video game. The game treats kids with ADHD, but the company has bigger plans. Chris Newmarker, executive editor of life sciences, returns with his newsmakers including CMR Surgical, Affera, Medtronic, Blackrock Neurotech, Cardinal Health, and Stryker. To hear the rest of our interview with CMR CEO Per Vergard Nerseth go here. https://www.devicetalks.com/hear-from-the-ceos-of-two-surgical-robotics-companies-that-together-just-raised-over-1-billion/ 5. https://www.massdevice.com/cmr-surgical-100-mark-versius-systems-installed/ 4. https://www.medicaldesignandoutsourcing.com/medtronic-affera-cardiac-ablation-catheter-mapping-design/ 3. https://www.massdevice.com/blackrock-neurotech-unveils-next-generation-bci-interface/ 2. https://www.massdevice.com/cardinal-health-hospital-level-care-home/ 1. https://www.massdevice.com/stryker-unveils-new-operating-room-model/ Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to this podcast on any major podcast application.

What Is a BCI? And just as importantly, what isn't a BCI? This is an unusual episode and an incredibly fun one. Arun and JoJo enlisted some of the field's top folks to talk through what's in and what's out in this exciting field. https://www.linkedin.com/in/amyakruse2020/ (Amy Kruse) is a general partner at Prime Movers Lab and a self-professed Founder turned Funder (and a neuroscientist by training), https://www.linkedin.com/in/matt-angle-6aa34850/ (Matt Angle) is the founder and CEO of Paradromics - developing high data rate BCIs, and https://www.linkedin.com/in/marcus-gerhardt-1583524/ (Marcus Gerhardt) is the co-founder and CEO of Blackrock Neurotech and is hoping that their BCIs will disrupt the standard for patient care for the 600 million people that suffer from neurological disorders.  This episode has it all - technical glitches, laughter, ruffled feathers (Arun's specialty), and some tantalizing discussions around definitions, dystopia, and delivering on the promise of this incredible technology.  Arun picks at and Matt defends the valuations of BCI companies - replete with funny characters and great voice acting. Amy chimes in with her point of view (plot twist: she's on the side of massive market potential) while Marcus makes the claim that BCI companies are, in fact, under valued. In short, this episode is pretty much your best chance at eavesdropping on a tantalizing conversation among some truly brilliant people on a fascinating topic.  SKRAPS is your podcast, where we on your behalf explores unsaid, under-appreciated and sometimes, untold stories of sparks of brilliance in science, technology and innovation. Show Credits Created & Produced by: https://www.linkedin.com/in/arun11sridhar/ (Arun Sridhar) & https://www.linkedin.com/in/jojoplatt/ (JoJo Platt) Editing: Arun Sridhar Social Media: Twitter: https://twitter.com/PodcastSkraps (@PodcastSkraps) LinkedIn: https://www.linkedin.com/company/skrapspodcast (SKRAPS) https://twitter.com/skrappyscience (Arun's Twitter Feed) https://twitter.com/RockinRedSF (JoJo's Twitter Feed) You can help us fund the production costs by donating as little as $5 or £5 or in any currency of your choice as a one time or a recurring payment HERE

The Sunday Times' tech correspondent Danny Fortson brings on Marcus Gerhardt, chief executive of Blackrock Neurotech, to talk about his boarding school days in Wales (4:00), his dotcom adventures (10:00), pivoting to brain-computer interfaces (16:00), the “Utah array” (18:40), how in 2006 the first person sent an email with his thoughts (20:30), starting the company (23:00), the state of the technology today (26:40), targeting tetraplegics (33:00), getting investment (38:15), going to market (41:30), and reaching an inflection point (47:40). Hosted on Acast. See acast.com/privacy for more information.

In this very special two part series in collaboration with Blackrock Neurotech, Paradromics CEO Matt Angle and Blackrock Creative Director Taryn Southern co-host a discussion with BCI research pioneers Jan Scheuermann, Ian Burkhart, and Nathan Copeland. In part one, we discuss their personal journeys to becoming BCI pioneers, implant experiences with the Utah Array,  their time in the lab, and some of their current projects. Learn more about Jan, Ian, and Nathan below and stay tuned for part two, coming in July 2022! The Panel: Jan Scheuermann is an author and public speaker, and self-styled “professional lab rat.” She has spoken at DARPA, the Johns Hopkins Applied Physics Laboratory, and the National Convention of the ALS Association about her experience as a BCI trial participant at UPitt. She is the author of a fictional mystery novel, Sharp as a Cucumber, available on Amazon. You can find out more about Jan and book her for public speaking events on her website or connect with her on LinkedIn. Ian Burkhart is the President of the Ian Burkhart Foundation, which provides equipment not typically covered by insurance that improves independence for those with spinal cord injuries. He is also the Vice President of the North American Spinal Cord Injury Consortium, an advocacy organization that brings individuals with lived experience together with researchers to improve research, care, cure, and policy. In addition, Ian consults on medical device development and user interaction. Ian's latest project is the BCI Pioneers Coalition, a platform to connect BCI users, researchers, industry, and other stakeholder groups to discuss the future of Brain Computer Interfaces. You can visit him on his website or connect with him on LinkedIn, Twitter, and Instagram. Nathan Copeland is a neurotechnology consultant, speaker, and digital artist. He has spoken at numerous conventions around the world about his experiences in the lab and has been featured in many prominent publications including, but not limited to, Wired, MIT Tech Review, NPR, Fortune, and the Atlantic. He is the creator of the first BCI NFTs, available on OpenSea. You can connect with Nathan on Instagram, Twitter, and Linkedin. 00:00 | Intro6:10 | Who came first?7:07 | Jan Scheuermann7:18 | Tim Hemmes & the UPitt/UPMC Team8:05 | New Yorker profile of Jan and the UPitt team8:55 | View Jan's photos from the lab10:10 | Nathan Copeland13:00 | Parietal Cortex13:22 | Saccade Movements14:12 | The Pioneer Experience16:04 | Neuro Life Study | Additional Reference | Interview with Ian | Archives of PMR18:15 | Mirror Therapy23:50 | Jan in the Pilot Seat25:07 | Ian's Experience in the Car Simulator25:53| Thinking About Thinking31:24 | Jan's novel, Sharp as a Cucumber37:37 | View Jan's photos from the lab38:04 | Andy Schwartz38:45 | Nathan's NFTs43:22 | Nathan's Instagram45:03 | 15 Minutes of Fame45:12 | A Presidential Greeting45:45 | Jan on 60 Minutes45:54 | Jan in SciAM46:00 | Book Jan as a keynote speaker46:32 | SfN47:05 | Investment in BCI47:17 | The Ian Burkhart FoundationWant More?Follow Paradromics on Twitter, LinkedIn, and InstagramFollow Blackrock Neurotech on Twitter, LinkedIn, and InstagramFollow Taryn on LinkedIn, Instagram, and TwitterFollow Matt on LinkedIn and Twitter

This week we spoke to Nathan Copeland, an individual who has received a Blackrock brain-computer interface implant in both his somatosensory cortex and motor cortex. Nathan is an invasive brain-computer interface user and neurotechnology consultant. In 2004, he was in a car accident that left him with a C5 spinal cord injury and resulting quadriplegia. He later joined the Rehab Neural Engineering Lab at the University of Pittsburgh Medical Center to test brain-computer interface devices to control a robotic arm, an exoskeleton glove, play video games, and make art. His work over the last 7 years has resulted in major contributions to science. Currently, Nathan is working as a neurotechnology consultant for Blackrock Neurotech and, on his own time, has started making and selling NFTs on OpenSea drawn entirely with his brain-computer interface! Links from this episode:Nathan's Twitter: https://twitter.com/bcicandobetterNathan's SuperRare: https://superrare.com/artwork-v2/you-are-loved-32211Nathan's OpenSea: https://opensea.io/BCIcanDoBetter Nathan's Instagram: https://www.instagram.com/bcicandobetter/ Support us: https://www.bciguys.com/supportFollow us on Social Media!Twitter: https://twitter.com/bciguys​​Instagram: https://www.instagram.com/bciguys/​​Website: https://www.bciguys.comYouTube: https://www.youtube.com/c/TheBCIGuys

For some people, a critical link – the one sending signals from brain to body, the one connecting thought to action – does not work properly, or in some cases, has been severed entirely. Marcus Gerhardt, CEO and co-founder of the Salt Lake City, UT-based company Blackrock Neurotech, is creating a technology called a brain-computer interface. The tiny implant aims at restoring the connection between mind and motion. On this episode of Here's an Idea, Gerhardt explains how a millimeter-sized device, when placed on the brain, offers quadriplegic patients (those with paralysis of all four limbs) and tetraplegic patients (those who cannot move the upper and lower parts of their body) the chance to move a cursor, eat a chocolate bar, and even fist-bump the President. See how a brain-computer interface works.

Thinking to type sounds interesting to most of us. Crazy and futuristic, yes, but also freeing and fast. But for those with massive spinal cord injuries or degenerative diseases, it's an absolute lifeline. In this TechFirst, we chat with Marcus Gerhardt, CEO of Blackrock Neurotech, about a brain-computer interface they've invented, "installed" for people who cannot use their arms or legs anymore, and enabled typing, speech, and the use of robotic arms to feed themselves and more. Blackrock's tech enables thought-to-text typing at 90 characters per minute with 94% accuracy (just imagine what Dr. Stephen Hawking could have done with this) and gives tetraplegic patients the power to move a prosthetic arm, grab a glass of water, and drink by themselves again for the first time since their tragic accidents. Links: Blackrock Neurotech: https://blackrockneurotech.com Buy $SMRT to join a community focused on tech for good: the emerging world of smart matter. Access my private Slack, get your name in my book, suggest speakers for TechFirst ... and support my work. TechFirst transcripts: https://johnkoetsier.com/category/tech-first/ Forbes columns: https://www.forbes.com/sites/johnkoetsier/ Full videos: https://www.youtube.com/c/johnkoetsier?sub_confirmation=1 Keep in touch: https://twitter.com/johnkoetsier

In this episode of Medsider Radio, we're sitting down with Marcus Gerhardt, who has started multiple companies, including an eCommerce platform and international consulting firm. In 2008, he co-founded Blackrock Neurotech, a pioneer in brain-computer interface (BCI) technology, and the world's leading collaborative partner for developing approved medical devices at scale for neurological therapies. He currently serves as CEO and is on the company's board.In this episode of Medsider, Marcus explains why Blackrock's business model works for medtech companies, how the approach gave the company an “in” with the neuroscience research community, and why medical device companies need to work with — and not against — regulatory bodies like the Food and Drug Administration (FDA). Before we jump into the conversation, I wanted to mention a few things:If you're into learning from proven medtech and healthtech leaders, and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You'll get access to gated articles, and lots of other interesting healthcare content.Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced healthcare leaders about the nuts and bolts of running a business and bringing products to market. This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.In addition to the entire back catalog of Medsider interviews over the past decade, Premium members get exclusive Ask Me Anything interviews and masterclasses with some of the world's most successful medtech founders and executives. Since making the premium memberships available, I've been pleasantly surprised at how many people have signed up. If you're interested, go to medsider.com/subscribe to learn more.Lastly, here's the link to the full interview with Marcus if you'd rather read it instead.

On Cool Science Radio, John and Lynn speak with Marcus Gerhardt, Co-founder & CEO of Blackrock Neurotech, a biotech company based in Salt Lake City.

Professor Florian Solzbacher is the Co-Founder and Chairman of Blackrock Neurotech and is focused on expanding the options, understanding, and marketing of brain computer interfaces and neuro devices. I asked Florian about their new project underway with Northwestern University and DARPA called the NTRAIN Project. He said, "The key driving force behind that project is to try and help counter the effects of jet lag and dysfunctions in the circadian rhythm. All those of us who have been traveling internationally a lot will know that it usually takes you a few days to adjust your inner clock to a different time zone that you're in." "What has been shown in initial research is that there are ways to help adjust the internal clock by essentially generating some of those same peptides that regulate our circadian rhythm. Then releasing them into the bloodstream on demand essentially sends clear clock signals through the body that allow you to adjust faster than you normally would." @BlackrockMicro #innovation #Neuroscience #Neurotechnology #BCI #Technology #Neurotech #RestoringFunction #TouchAgain #FeelAgain #TalkAgain #MoveAgain #BCIPioneer #braincomputerinterface #Research BlackrockNeurotech.com Download the transcript here

Professor Florian Solzbacher is the Co-Founder and Chairman of Blackrock Neurotech and is focused on expanding the options, understanding, and marketing of brain computer interfaces and neuro devices. I asked Florian about their new project underway with Northwestern University and DARPA called the NTRAIN Project. He said, "The key driving force behind that project is to try and help counter the effects of jet lag and dysfunctions in the circadian rhythm. All those of us who have been traveling internationally a lot will know that it usually takes you a few days to adjust your inner clock to a different time zone that you're in." "What has been shown in initial research is that there are ways to help adjust the internal clock by essentially generating some of those same peptides that regulate our circadian rhythm. Then releasing them into the bloodstream on demand essentially sends clear clock signals through the body that allow you to adjust faster than you normally would." @BlackrockMicro #innovation #Neuroscience #Neurotechnology #BCI #Technology #Neurotech #RestoringFunction #TouchAgain #FeelAgain #TalkAgain #MoveAgain #BCIPioneer #braincomputerinterface #Research BlackrockNeurotech.com Listen to the podcast here

Boosters, Hillsong Divided, BlackRock, Neurotech - CCNT 370 Our LINK TREE: CanaryCry.Party SUBSCRIBE TO US ON: NewPodcastApps.com PAYPAL: https://bit.ly/3v59fkR MEET UPS: https://CanaryCryMeetUps.com   INTRO 0:01:49  Photo of infrastructure bill (image) Woman with cyst, still pushes jab (Clip)   FLIPPY 0:10:13  Latvian Kitchen Robot makes new Fast Food (Deccan Herald)   33 0:17:12  Britain, positive cases down 33% (Reuters) Pfizer expects $33 billion profit (Bloomberg)   WACCINE/PANDEMIC SPECIAL 0:23:52 Protests Worldwide Germany protests persist (Fox) - 600 in Berlin detained (AP) Protests in France continues (AP) Israel protests new lockdown measures (Guardian) Israel to roll out Pfizer booster shots for older population (Biz Insider) Pfizer CEO announces boosters every 6 months (Clip) Italy protests against jab (Times of Israel) Compulsory workplace jab cannot apply to British Vegans (Telegraph) Pakistan wants NCOC to block sim and social media for jab resisters (WION) Thai Media companies demand Gov revise new News restrictions (ChiangraiTimes) Russian entrepreneurs QR code tattoo for jab status (Calvert Journal) Jab in the USA Jab not enough to stop Delta Variant (CNN) SoCal Hillsong member, Corona man, Covid denier, dies of “Covid”…maybe (KCAL) Harmon death was from Bacterial Pneumonia (The Sun) CDC, FDA “faked” covid tests, debunked (En_pneumati email)  If Jab Refusniks win, forget beating Covid (Sunday Guardian) [Refusnik]   BREAK (producer party) 1:41:05    POLYTICK 2:30:32  Kamala “Underwater” with popularity (Telegraph) Activists serve Pelosi “eviction notice” at her home in SF (Fox)  LA Mayor Garcetti house vandalized after homeless bill passed (NBC LA) Biden gives a kid his used mask (Clip) LAPD admits it needs better projectile tracking, and ways to deal with Indie Journalists (CBS) Long Island county votes on bill that can allow police to sue protestors (CNN)   GREAT RESET/CLIMATE CHANGE 3:01:00 Brookings Institute survey's top nations and their SDG progress, US “behind” (Brookings Institute) Climate Activists get boost from BlackRock (Morningstar) CEO of BlackRock, Larry Fink, letter to companies (BlackRock) Hundreds of Alabama Coal Miners protest in front of BlackRock's NYC HQ (Fox Business)   CYBORG 3:16:36  BlackRock Neurotech discusses “Living Pharmacy” device (UPR)   PRODUCERS ep. 370: Spearsdesert, John C, 1MakinTX, Gyeongmin J, Scott K, Emily T, Willem, Big Tank, James H, Cherie H, Doughty the Coyote, Veronica D, Gail M, Kim W, Tristan H, Dalton, Niki U, Kathy G, Dustin, BigAxe 007, AnUnquiet Soul, Laura I   TIMESTAMPS: Christine C   JINGLES: Marty B   ART: Dame Allie Sir Dove, Knight of Rustbeltia Grace

Dr Florian Solzbacher is the Co-Founder and Chairman of Blackrock Neurotech which has the Utah Electrode Array, the only FDA-approved neural implantable device. Blackrock Neurotech recently closed a $10 million financing round, led by Christian Angermayer's re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact's University Venture Fund II.   Top 3 Takeaways "In the end, you have to have the drive. It has to be a passion. And then you will find a way because very often in life, you will find that, just when you need it, all that you really need is one door opening at the right time” "The worst thing that can happen to this field is this sort of Hollywood-type hype and associated fear… 'people put chips into our brain and then they can read my thoughts” "You need to understand that you stand and fall with a team" 2:00 "You got a round of $10 million. So do you want to talk about this?" 10:45 "So are you saying then that they're not as interested in the prosthetic side of things but they really want to improve the bandwidth between consciousness and machines?" 16:00 "What do you plan to do with the money? Because $10 million is a lot of money, but at the same time, it's not a lot of money. That's like what you were saying, that's two studies, right?" 17:30 "I'm curious to hear your history of the company and how it's progressed over the last few decades." 25:30 "What advice do you have for listeners who want to do not only science, not only neuroscience, but engineering, science, business, and development?" 33:45 " Is there anything that we didn't talk about that you wanted to mention?"

Welcome to the Season 1 finale of Neurotech Pub! In this episode, host and Paradromics CEO, Matt Angle, speaks with fellow Neurotech CEOs, Konstantinos Alataris, Frank Fischer, and Marcus Gerhardt. "We cover a lot in this discussion, but one of the big themes is how challenging it can be to raise money, to build neuro devices. This episode was originally recorded last winter, and it was instantly one of my favorite episodes. So like a fine wine, I laid it down until the time was right to share it with friends.Since the episode was recorded, Nesos, Paradromics, and BlackRock all had major funding announcements. Nesos and BlackRock underwent rebranding campaigns, and NeuroPace went public on Nasdaq. This podcast was recorded during a bleak winter, but our optimism proved prescient. The podcast aged well, and now the field is the strongest, best funded, and most exciting that it's ever been. I know you'll enjoy the discussion."- Matt Angle, CEO, ParadromicsCheck out full video with transcript here: https://www.paradromics.com/podcast/neurotech-pub-episode-9-building-and-funding-neurotech-companies 01:08 | Meeting Heros08:02 | Company Origins: NeuroPace, Blackrock Neuro, and Nēsos25:28 | Now vs Then, a Decade of Neurotech Entrepreneurship1:04:50 | Investor Backing in Neurotech1:20:44 | BCI Future Is UnderwayWant more? Follow Paradromics & Neurotech Pub on Twitter  Follow Matt A, and Blackrock Neurotech on Twitter